|
Mj Biotech, Inc.
The Internet Services & Social Media industry advisors start to analyze the fourth quarter of 2018 numbers. Today those advisors follow operating profit of $5.761972 millions, from the BNBI, which hasn't stated any revenue yet, for the respective October to December 31 2018 financial reporting period.
Mj Biotech, Inc. Customers
Mj Biotech, Inc. rise Rates, Profitability, PE
Ascent Industries Co
For the financial interval ending December 31 2022 Ascent Industries Co income fell sharply by -98.68 % of $0.01 per share compare to $0.82 a year prior and earnings per share dropped by -81.86 % from $0.06 per share from the previous reporting season.
Revenues decreased in double digits by -14.747 % to $81.56 millions from $95.67 millions in the same reporting season a year prior and sequentially Revenues fell by -18.576 % from $100.17 millions.
Ascent Industries Co Customers
Ascent Industries Co Suppliers
|
Reading International Inc
For the fourth quarter of 2022 company recorded a shortfall per stock of $-0.54 per share compare to $0.02 a year prior and increased shortfall from $-0.23 per share from the prior financial reporting period.
Revenues decreased by -5.427 % to $47.21 millions from $49.92 millions in the corresponding financial reporting period a year prior and sequentially Revenue deteriorated by -7.79 % from $51.20 millions.
Reading International Inc Customers
Reading International Inc Revenue improvement Rates
|
|
Recently Reported Results |
Aspira Women S Health Inc
For the fourth quarter of 2022 AWH lost money of $-0.04 per share compare to $-0.08 a year prior and from $-0.04 per share from the prior reporting period.
Revenues grew extensively by 16.316 % to $2.15 millions from $1.85 millions in the comparable reporting period a year prior and sequentially Revenues surged by 3.909 % from $2.07 millions.
Aspira Women S Health Inc Suppliers
Aspira Women S Health Inc Revenue rise Rates
|
Quaint Oak Bancorp Inc
For the fourth quarter of 2022 earnings season Quaint Oak Bancorp Inc income per share plummeted by -44.5 % of $0.55 per share compare to $0.99 a year before and profit plummeted by -55.19 % from $1.22 per share from the previous reporting period.
Revenues depreciated by -6.343 % to $8.80 millions from $9.40 millions in the comparable reporting period a year before and sequentially Revenues fell by -26.514 % from $11.98 millions.
Quaint Oak Bancorp Inc Customers
Quaint Oak Bancorp Inc Suppliers
|
Socket Mobile Inc
In the Dec 31 2022 report Computer Hardware company announced soft top and bottom-line, where reached 0 and revenue by -15.427 % year on year. Revenue were to $5.17 millions in proportion to $6.11 millions eps at $0.00 in contrast to $0.09 in the financial period ending December 31 2021.
Socket Mobile Inc Competitors, Market Share
Socket Mobile Inc growth Rates, Profitability, PE
|
Better Therapeutics Inc
Following the big players in the Medical Equipment & Supplies industry, a number of smaller corporations are coming in with their earnings. Better Therapeutics Inc revealed it has announced operating deficit of $-8.322 millions, for the fourth quarter of 2022.
Better Therapeutics Inc stock quotes, charts, profile
Better Therapeutics Inc rise Rates, Profitability, PE
|
Aptevo Therapeutics Inc
For the fourth quarter of 2022 earnings season Aptevo Therapeutics Inc decreased a loss per share of $-0.84 per share compare to $-1.28 a year ago and EPS improved from $-1.50 per share from the prior quarter.
Revenues remained unaltered to $0.00 millions from $3.67 millions in the similar quarter a year ago and sequentially Revenues surged from $0.00 millions.
Aptevo Therapeutics Inc Customers
Aptevo Therapeutics Inc Income Statement, Balance sheets, Cash Flow Statement
|
Candel Therapeutics Inc
Shifting our regard to the fourth quarter of 2022 CADL Losses have expanded at $-0.15 per share, relative to the earnings of $1.54 per share a year prior financial reporting period, In the prior financial reporting period CADL realized $-0.30 per share.
Candel Therapeutics Inc Suppliers
Candel Therapeutics Inc Suppliers
|
|
|
|
Recently Reported Results |
Mj Biotech, Inc.
Following the bellwethers in the Internet Services & Social Media sector, a number of lesser known companies are reporting the earnings. BNBI mentioned it has realized operating surplus of $5.761972 millions, for the fourth quarter of 2018.
Mj Biotech, Inc. Suppliers
Mj Biotech, Inc. Income Statement, Balance sheets, Cash Flow Statement
|
Construction Spending
Outlays for U.S. construction projects increased again after dipping in the last month, led by growth in construction outlays for health care, residential and nonresidential construction.
Construction spending by category
Growth in construction outlays
|
Aei Income And Growth Fund Xxi Limited Partnership
For the fourth quarter of 2022 earnings season Aei Income And Growth Fund Xxi Limited Partnership income turned positive of $0.01 per share compare to $-0.14 a year before and Income per Share dropped by -99.63 % from $1.64 per share from the previous reporting season.
Revenues faded by -37.649 % to $0.19 millions from $0.31 millions in the corresponding reporting season a year before and sequentially Revenue Tumbled by -49.218 % from $0.38 millions.
Aei Income And Growth Fund Xxi Limited Partnership Customers
Aei Income And Growth Fund Xxi Limited Partnership Revenue elevation Rates
|
Creative Media And Community Trust Corporation
For the fiscal period ending December 31 2022 Creative Media And Community Trust Corporation Losses have extended of $-0.39 per share compare to $-0.38 a year before and EPS improved from $-0.50 per share from the preceding reporting period.
Revenue grew gently by 2.957 % to $25.87 millions from $25.13 millions in the comparable reporting period a year before and sequentially Revenues grew by 4.084 % from $24.85 millions.
Creative Media And Community Trust Corporation stock quotes, charts, profile
Creative Media And Community Trust Corporation Suppliers
|
Aspira Women S Health Inc
For the October to December 31 2022 interval AWH lost money of $-0.04 per share compare to $-0.08 a year ago and from $-0.04 per share from the preceding reporting season.
Revenues inched up admirably by 16.316 % to $2.15 millions from $1.85 millions in the corresponding reporting season a year ago and sequentially Revenues surged by 3.909 % from $2.07 millions.
Aspira Women S Health Inc Suppliers
Aspira Women S Health Inc Suppliers
|
Consumer Price Index
U.S. Consumer prices rose again after dipping in the last month, led by increase in gasoline prices.
|
Employment Report
The nonfarm payrolls grew 223,000 in December, as faster hiring puts more money in the hands of consumers, what usually leads to an increase in spending,
|
Housing Starts
|
Quaint Oak Bancorp Inc
For the fourth quarter of 2022 company earnings per share plummeted by -44.5 % of $0.55 per share compare to $0.99 a year ago and profit plummeted by -55.19 % from $1.22 per share from the preceding financial reporting period.
Revenues decreased by -6.343 % to $8.80 millions from $9.40 millions in the same financial reporting period a year ago and sequentially Revenues fell by -26.514 % from $11.98 millions.
Quaint Oak Bancorp Inc stock quotes, charts, profile
Quaint Oak Bancorp Inc Suppliers
|
Socket Mobile Inc
In the fourth quarter of 2022 financial report SCKT disclosed soft top and bottom-line, where reached break-even and revenue by -15.427 % year on year. Revenue were to $5.17 millions in proportion to $6.11 millions eps at $0.00 compared to $0.09 in the same span a year prior.
Socket Mobile Inc Competitors, Market Share
Socket Mobile Inc rise Rates, Profitability, PE
|
Better Therapeutics Inc
The Medical Equipment & Supplies sector experts start to scrutinize the fourth quarter of 2022 results. Today those experts observe operating deficit of $-8.322 millions, from the company, as it hasn't specified any top-line yet, for the respective October to December 31 2022 reporting period.
Better Therapeutics Inc Suppliers
Better Therapeutics Inc Income Statement, Balance sheets, Cash Flow Statement
|
Aptevo Therapeutics Inc
For the fourth quarter of 2022 Aptevo Therapeutics Inc decreased a loss per share of $-0.84 per share compare to $-1.28 a year ago and EPS improved from $-1.50 per share from the preceding financial reporting period.
Revenues remained unchanged to $0.00 millions from $3.67 millions in the corresponding financial reporting period a year ago and sequentially Revenues surged from $0.00 millions.
Aptevo Therapeutics Inc Competitors, Market Share
Aptevo Therapeutics Inc rise Rates, Profitability, PE
|
Candel Therapeutics Inc
Considering the October to December 31 2022 period the Biotechnology & Pharmaceuticals company Diminishing Returns have extended at $-0.15 per share, relative to the recent numbers of $1.54 per share a year before reporting season, In the preceding reporting season the Candel Therapeutics Inc realized $-0.30 per share.
Candel Therapeutics Inc Suppliers
Candel Therapeutics Inc advance Rates, Profitability, PE
|
Invesco Db G10 Currency Harvest Fund
In the most recent fiscal period DBV reached 0 at $0.00 per share, opposite of $0.00 per share a year before quarter, In the prior quarter The company realized $0.00 per share.
Invesco Db G10 Currency Harvest Fund stock quotes, charts, profile
Invesco Db G10 Currency Harvest Fund Suppliers
|
|
|
|
|